Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-24

Clinical Trial Update: The Role Of Omega-3 Fatty Acids In Adolescent Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating omega-3 fatty acids for adolescents with major depressive disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2017-05-24